in other words, () drugs are both prescription and OTC drug products, being patronized by doctors and direct end-users. The latter could readily buy said product in drugstores even without prescription. Some OTC drug products are also classified as proprietary drug products.

are OTC drug products that are promoted and marketed to endusers or mass-based consumers through radio, TV print advertisements, mass sampling, consumer sales promotions and special events. However, not all OTC-drugs can be advertised in the tri-media. Antibiotics, anti-TB, cardiovascular, and hypertensive drugs, steroids, and other specialty products classified as regulated drugs can neither be advertised in the trimedia nor classified as proprietary drugs. A majority of ()are in the category of analgesics-antipyretics, cough-colds, vitamin-mineral preparations and health foods.

are available in the thousands of drugstores, groceries and supermarkets, trading stores, and sari-sari stores, and can be bought anytime from said outlets without a doctor’s prescription, anywhere in the country.

The most important development within the national scene which has direct bearing on the Pharmaceutical Industry was the formulation of the () last () and the signing into law of the () of 1988 now known as Republic Act () by the former President Corazon C. Aquino.

The covering guidelines were released, and the stage set for the full implementation during the administration of former Secretary of Health,

The Generics campaign has been revitalized under the leadership of former DOH Secretary, () and relentlessly pursued by the current DOH Secretary, ()

Favorable Factors and Circumstances Prior to the Implementation of (PNDP): 1. The new government following the peaceful EDSA revolution of (). 2. ()() development-oriented officials at the helm of the Department of health (DOH). 3. The strongly felt and expressed need to provide essential () of high quality, safety, and efficacy to the people.

4. The construction of modern laboratory facilities for the ()()) under a () grant started in 1986 and completed in 1987.

5. The ongoing Cooperation Project in Pharmaceuticals among ASEAN countries supported by the () and the World Health Organization (WHO) beginning in the early 1980s.

6. The worldwide concern about the problem of inadequate access to ()drugs and the irrational use of drugs.

 is to make essential drugs available, accessible, and affordable to the people, a goal duly supported by the leaders in the drug industry and very much welcomed by health professionals and the general public.

() of the safety, efficacy and usefulness of pharmaceutical products through quality control. This will involve the regulation of the importation, manufacture, marketing, and consumer utilization of all drugs and their intermediates.

The promotion of the ()l use of drugs by both health professionals and the general public. Rational use of drugs refer to a carefully considered pattern of behavior on the part of the prescriber and the consumer. This will limit the use of medicines to situations where there are clear valid indications for them. Furthermore, only the most necessary and scientifically proven efficacious drugs should be used.

Development of() in the local pharmaceutical industry. This pillar seeks to strengthen Filipino capabilities for the manufacture of basic and intermediate ingredients for drugs and medicines. By developing a capability to produce strategic essential drugs(), the country's dependence on imported drugs can be greatly reduced. This will also enable local drug manufacturers to be competitive with the transnational drug firms.

Despite the presence of most of the () or perhaps because of it, the Philippine Pharmaceutical Industry remained largely dependent on () active ingredients and excipients used in the manufacture of the finished pharmaceutical dosage forms. Although 90-95% of the products in the Philippine market were manufacture locally, the drug industry remained merely a formulating, compounding, and packaging industry largely controlled by foreign-owned TNCs (NDP Report, 1987-1992).

The tailored or targeted procurement of drugs by () with the objective of making available to its own clientele, particularly the lower‐income sectors of the society, the best drugs at the lowest possible cost. It is widely acknowledged that the government is the single largest purchaser of drugs in the country, allocating major part of its health budget for drugs and medicines

This cuts across all the four pillars and aims to assist people in exercising an informed choice in the purchase of cost‐effective medicines

QUALITY OF HEALTH CARE INDICATORS 1. Related to product and /or Establishment a. % of products in () found substandard by BFAD b. % of products supplied to () found substandard by BFAD c. % of manufacturers classified according to ()classification scheme and consumption per capita.

2. Related to Health Professionals a. % of patients given treatment according to current () guidelines b. % of drugstore customers given proper() on drug use and risk by pharmacist.

3. Related to Product Information a. % of advertisements conforming with the (). b. Number of product advertisement claims found ()

B. HEALTH STATUS OF THE POPULATION INDICATORS 1. Life () at birth 2. Infant () rate 3. () mortality rate 4. Mortality rate of disease clusters; communicable diseases versus diseases of the (). 5. () and mortality 6. () death rates

C. EQUITY ACCESS 1. % of population covered with () drugs. 2. % of population given information on () products and prices under the generics Law.